Wed, March 30, 2022
Tue, March 29, 2022
Mon, March 28, 2022

Nathan Weinstein Initiated (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022

Nathan Weinstein of Aegis Capital, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022.

Nathan, nor any peers, have made any analyst calls on TRVI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30